Health Care & Life Sciences » Pharmaceuticals | Gennex Laboratories Ltd.

Gennex Laboratories Ltd. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
6,980.00
8,471.00
30,334.00
31,008.00
14,533.00
Depreciation, Depletion & Amortization
8,199.00
8,861.00
8,361.00
8,394.00
9,218.00
Other Funds
3,289.00
3,738.00
3,423.00
7,007.00
10,213.00
Funds from Operations
11,890.00
13,594.00
35,272.00
32,395.00
13,538.00
Changes in Working Capital
9,686.00
15,873.00
6,295.00
40,250.00
11,589.00
Net Operating Cash Flow
2,204.00
2,279.00
28,977.00
7,855.00
25,127.00
Capital Expenditures
9,662.00
2,435.00
12,531.00
10,014.00
7,620.00
Sale of Fixed Assets & Businesses
109.00
-
610.00
-
100.00
Net Investing Cash Flow
9,553.00
2,435.00
11,921.00
10,014.00
7,520.00
Issuance/Reduction of Debt, Net
7,694.00
6,596.00
14,143.00
14,388.00
17,682.00
Net Financing Cash Flow
7,694.00
6,596.00
14,143.00
15,686.00
13,719.00
Net Change in Cash
345.00
1,882.00
2,913.00
2,183.00
3,888.00
Free Cash Flow
7,458.00
4,714.00
16,446.00
17,869.00
17,507.00

About Gennex Laboratories

View Profile
Address
Akash Ganga
Hyderabad TS 500073
India
Employees -
Website http://www.gennexlab.com
Updated 09/14/2018
Gennex Laboratories Ltd. engages in the manufacture of bulk drugs and intermediates products. It operates through the following geographical segments: Germany, Egypt, Iran, Peru, Bangladesh, Spain, Guatemala City, El Salvador, Vietnam, Export Others, and India. Its products include Guaifenesin, Methocarbamol, Phenazopyridine Hydrochloride, Fluconazole, Metformin Hcl, Ambroxol Hcl, and Melitracen Hydrochloride.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.